Summary

Eligibility
for people ages 18-90 (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
completion around

Description

Summary

Official Title

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma: Study Protocol for An International Multicenter Prospective Cohort Study (ENCRAM 2302)

Details

Keywords

Glioblastoma, Glioblastoma Multiforme, Glioblastoma, IDH-wildtype, Glioblastoma Multiforme of Brain, Glioblastoma Multiforme, Adult, Recurrent Glioblastoma, Astrocytoma, Malignant, Astrocytoma of Brain, Radiotherapy, Chemotherapy, Re-resection, Resection, Overall survival, Progression-free survival, Neurological morbidity, Safety, Serious Adverse Events, Quality of life, Astrocytoma, Recurrence, Temozolomide, Lomustine, Re-irradiation, Experimental therapy, Best supportive care

Eligibility

Locations

  • UCSF accepting new patients
    San Francisco California 94143 United States
  • Massachusetts General Hospital accepting new patients
    Boston Massachusetts 02114 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Jasper Gerritsen
ID
NCT06283927
Study Type
Observational
Participants
Expecting 464 study participants
Last Updated